Jinling Pharmaceutical Co Ltd (000919) — Capital Reinvestment Ratio
Jinling Pharmaceutical Co Ltd (000919) has a Capital Reinvestment Ratio of 0.17x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥74.01 Million) in capital expenditures (CN¥12.56 Million). See debt-free asset ratio of Jinling Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jinling Pharmaceutical Co Ltd Capital Reinvestment Ratio (1999–2024)
This chart tracks Jinling Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 26 annual periods. Check Jinling Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year Capital Reinvestment Ratio for Jinling Pharmaceutical Co Ltd from 1999 to 2024. For live market cap and broader valuation context, see market cap of Jinling Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.31x | CN¥154.19 Million | CN¥201.63 Million | ▲ +11.6% |
| 2023 | 1.17x | CN¥158.92 Million | CN¥186.25 Million | ▼ -1.4% |
| 2022 | 1.19x | CN¥260.59 Million | CN¥309.64 Million | ▲ +113.2% |
| 2021 | 0.56x | CN¥292.03 Million | CN¥162.76 Million | ▼ -40.4% |
| 2020 | 0.94x | CN¥311.46 Million | CN¥291.41 Million | ▲ +246.7% |
| 2019 | 0.27x | CN¥465.85 Million | CN¥125.71 Million | ▼ -14.2% |
| 2018 | 0.31x | CN¥433.83 Million | CN¥136.42 Million | ▲ +108.6% |
| 2017 | 0.15x | CN¥443.11 Million | CN¥66.80 Million | ▼ -86.5% |
| 2016 | 1.12x | CN¥96.15 Million | CN¥107.45 Million | ▲ +127.6% |
| 2015 | 0.49x | CN¥212.45 Million | CN¥104.31 Million | ▲ +61.6% |
| 2014 | 0.30x | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥39.77 Million | CN¥71.57 Million | — |